Voltar
Artigo Revisado por pares
BIBTEX RIS

AILERON Therapeutics

2008; Wiley; Volume: 73; Issue: 1 Linguagem: Inglês

10.1111/j.1747-0285.2008.00744.x

ISSN

1747-0285

Autores

Tomi K. Sawyer,

Tópico(s)

Glycosylation and Glycoproteins Research

Resumo

Chemical Biology & Drug DesignVolume 73, Issue 1 p. 3-6 AILERON Therapeutics Tomi K. Sawyer, Tomi K. Sawyer Chief Scientific Officer and Senior Vice-President, Drug Discovery and Innovative Technologies, AILERON Therapeutics, Cambridge, MA, USASearch for more papers by this author Tomi K. Sawyer, Tomi K. Sawyer Chief Scientific Officer and Senior Vice-President, Drug Discovery and Innovative Technologies, AILERON Therapeutics, Cambridge, MA, USASearch for more papers by this author First published: 18 December 2008 https://doi.org/10.1111/j.1747-0285.2008.00744.xCitations: 16Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat Citing Literature Volume73, Issue1January 2009Pages 3-6 RelatedInformation

Referência(s)